Quantcast

Latest Colistin Stories

2014-09-16 08:30:15

Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 /PRNewswire/ -- Synereca Pharmaceutics, Inc. (SPI), a research-stage biopharmaceutical company developing novel orally active drugs that restore or increase the effectiveness of existing antibiotics, announced today a $1.4 million convertible debt financing. Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma, Inc.,...

2011-07-05 15:30:00

PARSIPPANY, N.J., July 5, 2011 /PRNewswire/ -- JHP Pharmaceuticals, a leading marketer and manufacturer of sterile injectable products, is launching larger pack sizes for three products commonly used in acute care clinical settings: Adrenalin® (epinephrine injection, USP), Coly-Mycin® M Parenteral (colistimethate sodium, USP) and Pitocin® (oxytocin injection, USP synthetic). Stuart Hinchen, CEO and President of JHP noted, "The larger...

2010-09-02 08:45:00

(Ivanhoe Newswire) -- An antibacterial peptide shows promise as an effective therapy against infections in burn or blast wounds suffered by soldiers. Laszlo Otvos, research professor of biology in Temple University's College of Science and Technology, and colleagues found that when given intramuscularly, the peptide A3-APO was more effective than current antimicrobial chemotherapy measures in treating multidrug-resistant Acinetobacter baumannii, the most common systemic infection found in...

2010-09-01 19:36:11

An antibacterial peptide developed by Laszlo Otvos, a research professor of biology in Temple's College of Science and Technology, looks to be a highly-effective therapy against infections in burn or blast wounds suffered by soldiers. Otvos and his collaborators found that when given intramuscularly the peptide A3-APO was more effective than current antimicrobial chemotherapy measures in treating multidrug-resistant Acinetobacter baumannii, the most common systemic infection found in soldiers...

2009-05-14 13:41:00

- Company receives clearance to add voriconazole to its YeastOne(R) susceptibility plate for in vitro diagnostics; plate now includes four FDA-cleared antifungal agents - New Research-Use-Only Sensititre(R) Xtra Gram Negative MIC Plate incorporates 21 antimicrobics, including colistin and polymixin B CLEVELAND, May 14 /PRNewswire/ -- TREK Diagnostic Systems, a Magellan Biosciences company and premier provider of diagnostic systems and susceptibility products for microbiology labs, will...

2009-03-30 17:53:23

Soldiers who survive severe injuries in Iraq and Afghanistan can be at risk of developing infections in their wounds, U.S. researchers say. Dr. Clinton K. Murray of Brooke Army Medical Center in San Antonio, Texas, said that at the beginning of the 20th century improved military hygiene and disease control led to a steady decline in wartime deaths attributable to infections, classically known as war pestilence, which included cholera, dysentery, plague, smallpox, typhoid and typhus fever....

2009-03-30 11:39:42

Soldiers who survive severe injuries on battlefields such as those in Iraq and Afghanistan can be at risk from developing infections of their wounds with multidrug resistant bacteria. The potentially lethal microbes include superbugs such as methicillin resistant Staphylococcus aureus (MRSA), Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella species and Escherichia coli.Dr Clinton K. Murray, from Brooke Army Medical Center, USA, told the Society for General Microbiology Meeting at...

2009-01-27 16:54:47

Infection now widespread among soldiers wounded in Iraq and Afghanistan Old technologies, bone cement and a well known antibiotic, may effectively fight an emerging infection in soldiers with compound bone fractures, according to a study published online today in the Journal of Orthopedic Research. An urgent search for solutions is underway as 20,000 additional American soldiers head for Afghanistan, and as evidence emerges that the infection studied may set the stage for more dangerous...

2008-10-28 12:00:39

HELSINKI, October 28 /PRNewswire/ -- Northern Antibiotics Ltd., the developer of novel polymyxin derivatives for the treatment of infections caused by multidrug-resistant Gram-negative bacteria, revealed today animal efficacy and pharmacokinetic data from their NAB compounds at the 48th Annual ICAAC/IDSA 46th Annual Meeting in Washington, DC. Northern Antibiotics has developed two series of novel polymyxin (NAB) compounds (Vaara M. et al., 2008, Antimicrob. Agents Chemother. 52:3229). The...


Latest Colistin Reference Libraries

72_ee74f19d6ec18e594c4d7bc49406908f
2011-04-14 16:11:25

Burkholderia pseudomallei is a Gram-negative, bipolar, aerobic, motile rod-shaped bacterium. It causes the disease melioidosis in humans and animals and is also capable of infecting plants. The bacteria can from in a number of artificial environments. Optimal temperature is around 40°C in pH-neutral or slightly acidic environments. Most strains can ferment sugars without gas formation. The bacteria produces both exo and endo toxins although the role of these toxins has not been fully...

More Articles (1 articles) »
Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related